Offaly Express5h
Tariffs on pharmaceutical exports ‘will damage prospects’ of US firms in Ireland
Proposed US tariffs on pharmaceutical exports will damage the economic prospects of US companies in Ireland, the Irish ...
Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report
The tariff increase is anticipated to result in higher drug costs and, in the medium term, increased insurance premiums for ...
U.S. Justice Department sting singes Hyderabad-based manufacturer of Fentanyl intermediary
It was from this corporate office of the Hyderabad-based pharmaceutical firm that a consignment of a Fentanyl precursor was ...
NDTV Profit17h
Indian Pharma Could Gain Market Share Amid US Tariffs, Says JPMorgan
In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...
Taiwan News1d
Active Pharmaceutical Ingredients Market Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031
The global active pharmaceutical ingredient market size was US$ 179.0 billion in 2021. The global active pharmaceutical ingredient market size is forecast to reach US$ 322.9 billion by 2030, growing ...
Conventus Law1d
Safeguards Of Dapagliflozin’s Half Billion USD Sales In China: Astrazeneca.
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: Astrazeneca. Legal News and Analysis - China - Conventus Law ...
Imports from China used for making finished products that are also exported: Commerce Department
India's imports from China rise due to raw materials for finished products, impacting trade deficit and bilateral relations.
Sigachi Management Insights: Key Takeaways From The March 2025 Meeting; Should You Keep The Stock On Radar?
Sigachi Industries Ltd. (SIGACHI) is the largest manufacturer of microcrystalline cellulose (MCC) excipient in India and in ...